Aveanna Healthcare Raises FY2023 Sales Outlook from $1.85B - $1.86B to $1.87B - $1.88B vs $1.86B Est
Portfolio Pulse from Benzinga Newsdesk
Aveanna Healthcare has raised its sales outlook for FY2023 from $1.85B-$1.86B to $1.87B-$1.88B, against an estimate of $1.86B. The company also updated its Adjusted EBITDA guidance from $132M-$135M to $134M-$137M. However, it did not provide guidance on net income due to the volatility of certain required inputs.
November 09, 2023 | 11:18 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aveanna Healthcare's raised sales and EBITDA outlook for FY2023 could potentially lead to a positive impact on its stock price in the short term.
Companies that raise their financial outlook are often viewed positively by investors as it indicates better than expected performance. This could lead to increased demand for the company's stock, potentially driving up the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100